1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Craneware plc

Craneware plc

CRWRF
Craneware plcUS flagOther OTC
16.20
USD
-8.00
- -
554.64MMarket Cap
Craneware plc
CRWRF
(Other OTC)

Recent

price

16.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
0.91
1.12
1.46
1.52
1.54
1.58
1.67
1.86
2.15
2.5
2.68
2.67
2.82
4.72
4.95
5.41
Revenue per Share
0.18
0.22
0.23
0.33
0.31
0.32
0.35
0.39
0.5
0.59
0.56
0.63
0.48
0.27
0.26
0.33
Basic EPS, GAAP
0.26
0.24
0.25
0.32
0.23
0.28
0.69
0.48
0.49
0.94
0.11
0.4
0.87
0.76
2.79
1.16
Free Cash Flow per Basic Share
0.08
0.12
0.12
0.15
0.17
0.2
0.2
0.22
0.24
0.29
0.32
0.34
0.36
0.37
0.34
0.37
Dividend per Share
0.25
0.38
0.65
0.81
0.95
1.08
1.11
1.3
1.5
1.11
1.36
1.61
1.77
1.22
1.15
1.14
Book Value per Share
0.69
0.81
0.6
0.8
0.96
1.13
1.17
1.35
1.47
1.06
1.1
1.18
8.1
-3.79
-3.53
-3.11
Tangible Book Value per Share
25
25
26
27
27
27
27
27
27
27
27
27
27
35
35
35
Basic Weighted Avg Shares
23
28
38
41
41
43
45
50
58
67
71
71
76
166
174
189
Sales/Revenue/Turnover
23.49
24.81
23.9
24.64
25.58
26.47
28.05
28.91
28.55
27.72
26.95
26.88
26.16
11.23
9.86
11.01
Operating Margin (%)
- -
- -
1
2
2
2
1
2
1
2
4
5
5
29
32
33
Depreciation Expense
4
6
6
9
8
9
9
11
14
16
15
17
13
9
9
12
Net Income, GAAP
24.22
23.87
30.49
20.61
21.76
23.74
24.87
24.05
19.89
16.56
18.21
12.78
1.97
28.19
29.45
25.68
Effective Tax Rate (%)
19.35
19.46
15.78
21.65
20.01
20.22
20.95
21.22
23.4
23.55
20.99
23.55
17.08
5.68
5.31
6.18
Profit Margin (%)
17
19
14
18
23
28
27
29
31
18
20
24
206
10
-13
-56
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
1
105
77
31
LT Debt
19
22
32
37
41
45
48
53
59
52
60
68
260
333
328
329
Total Equity
23.11
25.61
23.35
22.8
20.63
19.72
20.19
21.43
23.55
28.5
28.53
25.77
11.67
3.79
2.83
3.95
Return on Invested Capital (%)
88.02
69.65
45.52
45.98
34.98
31.42
31.78
32.69
35.96
45.01
45.39
41.08
27.11
12.52
9.6
14.96
Return on Capital (%)
88.02
69.65
45.52
45.98
34.98
31.42
31.78
32.69
35.96
45.01
45.39
42.41
28.49
20.83
22.13
29.06
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
35.37%
64.3%
0.23%
Free Cash Flow
71.16%
119.36%
-58.6%
Net Income, GAAP
4.8%
-2.64%
26.77%
Sales/Revenue/Turnover
19.37%
27.75%
8.76%
Total Cash Common Dividend
9.59%
9.29%
5.6%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
174
2024
- -
- -
- -
- -
189
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.26
2024
- -
- -
- -
- -
0.33
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.34
2024
- -
- -
- -
- -
0.37
2025
- -
- -
- -
- -
- -
Similar Companies
CareCloud, Inc. (MTBCP)
Health Discovery Corporation (HDVY)
Ping An Healthcare and Technology Company Limited (PANHF)
Intrasense S.A. (ALINS.PA)
Aclarion, Inc. (ACON)
CareCloud, Inc. (MTBC)
Business
Craneware plc develops, licenses, and supports software solutions primarily for the US healthcare industry, specializing in automated revenue integrity, pricing, cost support, and 340B/pharmacy management. Its core product portfolio includes the Trisus cloud ecosystem, which integrates revenue intelligence, margin intelligence, decision support, and advanced analytics to enhance financial performance for hospitals and health systems. The company offers software licenses, professional services including installation, and white-labeled solutions to healthcare providers. Craneware's flagship offerings include the Trisus Chargemaster, which has received Microsoft's "AI for Healthcare" certification and industry accolades such as "Best in KLAS." Founded in 1999 and headquartered in Edinburgh, United Kingdom, Craneware operates primarily in the US market. It serves a broad customer base of healthcare organizations, including hospitals, regional health systems, and teaching systems. The company emphasizes deep healthcare expertise combined with engineering excellence, positioning itself as a strategic partner in healthcare financial performance and operational improvements. Recent major developments include the acquisition and integration of Sentry Data Systems and Agilum Healthcare, enhancing Craneware’s 340B management and revenue cycle offerings. In 2025, Craneware secured a new $100 million revolving credit facility with a consortium of major banks to support potential acquisitions and business growth initiatives. The company reported a 9% revenue increase to $205.7 million for the fiscal year ended June 2025, alongside strong profitability and a 10% rise in dividends. Craneware also confirmed strategic contract wins, including multi-year agreements expanding the use of its Trisus platform across new hospitals and contract pharmacies. The company is currently engaged in a potential acquisition offer assessment by Bain Capital Private Equity. Craneware’s products and strategic initiatives solidify its leadership in healthcare financial software solutions, supporting clients in navigating the complexities of healthcare finance through advanced technology and data-driven insights. The company's continuous investments in product development and acquisitions aim to expand its market position and enhance its service offerings in the evolving US healthcare landscape.

Company News

APIChatGPT

  • proactiveinvestors.co.uk

    Craneware shares slump after slower conversion triggers profit warning

  • seekingalpha.com

    Craneware plc (CRWRF) Q2 2026 Earnings Call Prepared Remarks Transcript

  • defenseworld.net

    Craneware (OTCMKTS:CRWRF) Trading Down 24.5% – What’s Next?